Fibroblast Line Evaluation for COL5A eXpression and Thoracic Aortic Aneurysms: in Vitro Characterization of Cutaneous Fibroblasts in Adult Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-01-13

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study examines adults with COL5A gene mutations to understand why some develop aortic aneurysms while others do not. Participants provide a small skin biopsy, and researchers analyze fibroblasts to evaluate collagen production, extracellular matrix organization, and connective-tissue signaling pathways. The goal is to identify biological differences that may explain variable vascular risk and support future personalized monitoring and treatment strategies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fibroblasts and Thoracic Aortic Aneurysms: in Vitro Characterization in With Marfan Syndrome and Genetic Aortic Diseases

NCT06786754

Rare Diseases Thoracic Aortic Aneurysm (TAA) Marfan Syndrome

ENROLLING_BY_INVITATION

Study of in Vivo and in Vitro Transcriptomic and Proteomic Signatures in Unhereditary Ichtyosis

NCT05312073

Autosomal Recessive Congenital Ichthyosis Epidermolytic Ichthyosis

COMPLETED NA

Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients

NCT03558854

Systemic Sclerosis

COMPLETED PHASE4

Research Into the Molecular Bases of a New Phenotype Combining Premature White Hair, Polycystic Kidney Disease, Aortic Dilation/Dissection and Lymphopenia

NCT03651388

New Phenotype (Combining Premature White Hair, Polycystic Kidney Disease, Aortic Dilation/Dissection and Lymphopenia)

COMPLETED

Metabolomic Analysis of Systemic Sclerosis

NCT02298777

Scleroderma (Limited and Diffuse) Undifferentiated Connective Tissue Disease Raynaud Disease +2 more

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Individuals with mutations in the collagent type V, alpha (COL5A) gene show variable clinical outcomes. While some develop aortic aneurysms, others with the same mutation remain free of cardiovascular complications. The mechanisms driving this variability are not fully understood.

This study aims to investigate biological differences at the cellular level by analyzing fibroblasts derived from a small skin biopsy. Fibroblasts play a key role in the production and organization of type V collagen and the extracellular matrix.

Researchers will:

Grow fibroblasts from participants' skin samples.

Assess cell growth, migration, and extracellular matrix formation.

Measure the quantity and type of collagen produced.

Evaluate molecules involved in collagen breakdown and repair.

The study compares individuals with COL5A mutations who have documented aortic aneurysms to those with the same mutation but no vascular involvement. Analyses will also consider differences among family members who share the same genetic variant.

By characterizing fibroblast behavior, the study seeks to clarify why some individuals develop aortic disease while others remain unaffected. Findings may help identify cellular features associated with increased or reduced vascular risk and guide future strategies for monitoring, prevention, and personalized care in patients with COL5A mutations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mutations Affecting the COL5A Gene Aneurysm Aortic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Young patients with COL5A mutation and TAAD

Young patients (aged 18-50 years) with COL5A mutation and aortic manifestations

No interventions assigned to this group

Young patients with COL5A mutation without TAAD

Young patients (aged 18-50 years) with COL5A mutation in the absence of aortic manifestations

No interventions assigned to this group

Adult patients with COL5A with TAAD

Adult patients (aged over 50 years) with COL5A mutation and aortic manifestations

No interventions assigned to this group

Adult patients with COL5A mutation without TAAD

Adult patients (aged over 50 years) with COL5A mutation in the absence of aortic manifestations

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects aged 18 and above
* Mutation in COL5A
* Signed informed consent

Exclusion Criteria

* Corticosteroid or Steroids or Fluorochinolones treatment within six months before enrollment
* Subjects on chronic immunosuppressive therapies such as oral steroids, but also on chronic topical steroids in the area of investigation
* Subject on anticoagulant therapy
* History of coagulation factor defects/alterations (data found in anamnesis and medical records)
* A history of keloid formation (data found in anamnesis and medical records)
* Anesthetic drug allergy (data found in anamnesis and medical records)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No